171 related articles for article (PubMed ID: 28811239)
1. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.
Kunutsor SK; Laukkanen JA
Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239
[TBL] [Abstract][Full Text] [Related]
2. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
4. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
Kunutsor SK; Khan H; Laukkanen JA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
[TBL] [Abstract][Full Text] [Related]
5. Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study.
Kunutsor SK; Laukkanen JA
Lung; 2017 Dec; 195(6):799-803. PubMed ID: 28993933
[TBL] [Abstract][Full Text] [Related]
6. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study.
Kunutsor SK; Laukkanen JA
Alzheimers Dement; 2016 Sep; 12(9):931-941. PubMed ID: 27103259
[TBL] [Abstract][Full Text] [Related]
7. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis.
Fan Y; Jin X; Man C; Gong D
Free Radic Res; 2018 Aug; 52(8):819-825. PubMed ID: 30208797
[TBL] [Abstract][Full Text] [Related]
8. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence.
Kunutsor SK; Laukkanen JA; Bluemke DA; Butler J; Khan H
Eur J Prev Cardiol; 2016 Sep; 23(13):1354-62. PubMed ID: 27084895
[TBL] [Abstract][Full Text] [Related]
9. Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults.
Teppala S; Shankar A; Li J; Wong TY; Ducatman A
Kidney Blood Press Res; 2010; 33(1):1-6. PubMed ID: 20090360
[TBL] [Abstract][Full Text] [Related]
10. The relationship between gamma-glutamyl transferase levels and chronic kidney disease among Appalachian adults.
Cain LR; Ducatman AM; Shankar A
W V Med J; 2012; 108(1):8-13. PubMed ID: 25134186
[TBL] [Abstract][Full Text] [Related]
11. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
12. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men.
Ryu S; Chang Y; Kim DI; Kim WS; Suh BS
Clin Chem; 2007 Jan; 53(1):71-7. PubMed ID: 17110470
[TBL] [Abstract][Full Text] [Related]
13. High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent preictors of mortality in patients with stage 4-5 chronic kidney disease.
Caravaca-Fontán F; Azevedo L; Bayo MÁ; Gonzales-Candia B; Luna E; Caravaca F
Nefrologia; 2017; 37(3):267-275. PubMed ID: 28648203
[TBL] [Abstract][Full Text] [Related]
14. Serum Gamma-Glutamyl Transferase and Ferritin Synergistically Associated with the Rate of Chronic Kidney Disease.
Chen T; Ren Y; Gao Y; Tian H
Dis Markers; 2017; 2017():9765259. PubMed ID: 28659657
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
[TBL] [Abstract][Full Text] [Related]
17. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
Lee SR; Choi EK; Han KD; Cha MJ; Oh S
Int J Cardiol; 2017 Oct; 245():149-155. PubMed ID: 28757090
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer.
Hu G; Tuomilehto J; Pukkala E; Hakulinen T; Antikainen R; Vartiainen E; Jousilahti P
Hepatology; 2008 Jul; 48(1):129-36. PubMed ID: 18537182
[TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study.
Nano J; Muka T; Ligthart S; Hofman A; Darwish Murad S; Janssen HLA; Franco OH; Dehghan A
Int J Epidemiol; 2017 Oct; 46(5):1400-1409. PubMed ID: 28338987
[TBL] [Abstract][Full Text] [Related]
20. Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study.
Yadav D; Lee MY; Kim JY; Ryu H; Huh JH; Bae KS; Ahn SV; Chung CH; Park JT; Koh SB
Yonsei Med J; 2017 Jul; 58(4):763-769. PubMed ID: 28540989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]